NewAmsterdam Pharma Company
NAMS
#4070
Rank
S$3.06 B
Marketcap
$33.17
Share price
0.69%
Change (1 day)
162.27%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2024 (TTM): -S$0.25 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are S$14.02 Million. In 2023 the company made an earning of -S$0.24 Billion a decrease over its 2022 earnings that were of -S$32.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.25 Billion4.45%
2023 -S$0.24 Billion628.66%
2022-S$32.53 Million-48.69%
2021-S$63.4 Million444.1%
2020-S$11.66 Million